Plant ID: NPO3096
Plant Latin Name: Verbascum laxum
Taxonomy Genus: Verbascum
Taxonomy Family: Scrophulariaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
CA2; CA3; CA14; CA7; CA5A; CA4; CA6; CA12; CA9; CA1; CA5B; | |
ESR2; | |
HTT; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA5B | Carbonic anhydrase VB | Q9Y2D0 | CHEMBL3969 |
Nuclear hormone receptor subfamily 3 group A | ESR2 | Estrogen receptor beta | Q92731 | CHEMBL242 |
Unclassified | HTT | Huntingtin | P42858 | CHEMBL5514 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 4.966E-14 | 1.202E-10 | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR2 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 3.050E-35 | 6.642E-31 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.709E-28 | 1.861E-24 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 3.644E-26 | 1.983E-22 | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 1.254E-06 | 1.437E-03 | CA2, CA7 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 6.262E-06 | 6.494E-03 | CA1, CA2 |
BP | GO:0051179; localization | GO:2001225; regulation of chloride transport | 1.876E-05 | 1.776E-02 | CA2, CA7 |
BP | GO:0023052; signaling | GO:0032230; positive regulation of synaptic transmission, GABAergic | 3.248E-05 | 2.947E-02 | CA2, CA7 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 1.886E-34 | 1.697E-33 | CA12, CA1, CA3, CA5B, CA2, CA5A, CA4, CA7, CA6, CA9, CA14 |
09150 Organismal Systems | 09155 Excretory system | hsa04964 | Proximal tubule bicarbonate reclamation | 9.792E-05 | 4.406E-04 | CA2, CA4 |
09150 Organismal Systems | 09155 Excretory system | hsa04966 | Collecting duct acid secretion | 1.741E-02 | 5.224E-02 | CA2 |
09150 Organismal Systems | 09152 Endocrine system | hsa04917 | Prolactin signaling pathway | 4.582E-02 | 7.030E-02 | ESR2 |
09150 Organismal Systems | 09154 Digestive system | hsa04971 | Gastric acid secretion | 4.706E-02 | 7.030E-02 | CA2 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 4.519E-02 | 7.030E-02 | CA2 |
09150 Organismal Systems | 09152 Endocrine system | hsa04915 | Estrogen signaling pathway | 6.249E-02 | 7.030E-02 | ESR2 |
09150 Organismal Systems | 09154 Digestive system | hsa04972 | Pancreatic secretion | 6.065E-02 | 7.030E-02 | CA2 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05016 | Huntington's disease | 1.185E-01 | 1.185E-01 | HTT |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
NA: NA | Edema | NA | CA2; |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2; |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA2; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2; |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2; |